Nathaniel Owen, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 999 S Lapeer Rd, Oxford, MI 48371 Phone: 248-628-4283 |
Saeed Habeb Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 999 S Lapeer Rd, Oxford, MI 48371 Phone: 248-628-4283 |
Timothy Scott Davidson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1 S Washington St, Oxford, MI 48371 Phone: 248-628-5136 |
Mr. Donald Gregory Davidson, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 N Lapeer Rd, Oxford, MI 48371 Phone: 248-236-8010 Fax: 248-236-8065 |
Fjona Cara Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 N Lapeer Rd, Oxford, MI 48371 Phone: 248-236-8010 |
Erin Moss Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 999 S Lapeer Rd, Oxford, MI 48371 Phone: 248-628-4283 |
Richard M Parker, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 999 S Lapeer Rd, Oxford, MI 48371 Phone: 248-628-4283 Fax: 248-628-5887 |
Craig Dennis Crowe, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 765 S Lapeer Rd, Oxford, MI 48371 Phone: 248-628-7990 Fax: 248-628-6507 |
Dr. Jacob Sweeney, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 900 N Lapeer Rd, Oxford, MI 48371 Phone: 248-236-8010 Fax: 248-236-8065 |
Abraham Martin Beatty, RPH Pharmacist - Pharmacotherapy Medicare: Not Enrolled in Medicare Practice Location: 900 N Lapeer Rd, Oxford, MI 48371 Phone: 248-236-8033 Fax: 248-236-8065 |
News Archive
Watson Pharmaceuticals, Inc. today announced that it signed an agreement on February 26, 2010 to divest its equity ownership position of approximately 31% of ScinoPharm Taiwan Ltd. The transaction is subject to the parties obtaining approvals from various government agencies in Taiwan, as well as other customary closing conditions.
Johns Hopkins scientists have found that a method they developed to screen body fluids for certain kinds of cells and some of their genetic blueprint is twice as accurate at spotting breast cancer cells as a pathologist's view with a microscope.
Investigators at the Massachusetts General Hospital (MGH) Cancer Center have identified a new genetic signature associated with bile duct cancer, a usually deadly tumor for which effective treatment currently is limited.
Ipsen today announced that its partner, Inspiration Biopharmaceuticals, Inc., has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the approval of IB1001, an intravenous recombinant factor IX (rFIX) for the treatment and prevention of bleeding in individuals with hemophilia B.
Women smokers who become pregnant have long been encouraged to reduce or eliminate their nicotine intake.
› Verified 4 days ago